Oya M - Search Results

1

Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.

Ito K, Mikami S, Kuroda N, Nagashima Y, Tatsugami K, Masumori N, Kondo T, Takagi T, Nakanishi S, Eto M, Kamba T, Tomita Y, Matsuyama H, Tsushima T, Nakazawa H, Oya M, Kimura G, Shinohara N, Asano T. Ito K, et al. Among authors: oya m. Jpn J Clin Oncol. 2020 Oct 22;50(11):1313-1320. doi: 10.1093/jjco/hyaa114. Jpn J Clin Oncol. 2020. PMID: 33089867

2

Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.

Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M. Horiguchi A, et al. Among authors: oya m. J Urol. 2002 Aug;168(2):762-5. J Urol. 2002. PMID: 12131365

3

[What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?].

Oya M, Murai M. Oya M, et al. Gan To Kagaku Ryoho. 2002 Oct;29(10):1732-7. Gan To Kagaku Ryoho. 2002. PMID: 12402422 Japanese.

4

Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma.

Horiguchi A, Oya M, Uchida A, Marumo K, Murai M. Horiguchi A, et al. Among authors: oya m. J Urol. 2003 Feb;169(2):710-3. doi: 10.1097/01.ju.0000038952.59355.b2. J Urol. 2003. PMID: 12544348

5

Differential expression of activator protein-2 isoforms in renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M. Oya M, et al. Urology. 2004 Jul;64(1):162-7. doi: 10.1016/j.urology.2004.02.022. Urology. 2004. PMID: 15245963

6

Inhibition of the ubiquitin-proteasome pathway activates stress kinases and induces apoptosis in renal cancer cells.

Ishizawa J, Yoshida S, Oya M, Mizuno R, Shinojima T, Marumo K, Murai M. Ishizawa J, et al. Among authors: oya m. Int J Oncol. 2004 Sep;25(3):697-702. Int J Oncol. 2004. PMID: 15289872

7

C-jun activation in acquired cystic kidney disease and renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Marumo K, Mukai M, Murai M. Oya M, et al. J Urol. 2005 Aug;174(2):726. doi: 10.1097/01.ju.0000164656.99251.77. J Urol. 2005. PMID: 16006965

8

[Genetic backgrounds of renal cell carcinoma].

Oya M. Oya M. Nihon Rinsho. 2006 Feb;64 Suppl 2:593-6. Nihon Rinsho. 2006. PMID: 16523961 Review. Japanese. No abstract available.

9

Survivin associates with cell proliferation in renal cancer cells: regulation of survivin expression by insulin-like growth factor-1, interferon-gamma and a novel NF-kappaB inhibitor.

Sato A, Oya M, Ito K, Mizuno R, Horiguchi Y, Umezawa K, Hayakawa M, Murai M. Sato A, et al. Among authors: oya m. Int J Oncol. 2006 Apr;28(4):841-6. Int J Oncol. 2006. PMID: 16525632

10

[Treatment of renal cell carcinoma with interferons].

Oya M. Oya M. Nihon Rinsho. 2006 Jul;64(7):1281-5. Nihon Rinsho. 2006. PMID: 16838645 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,236 results

Search Page

Filters